<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism</title>
				<funder ref="#_vQyhKBB">
					<orgName type="full">USDA</orgName>
				</funder>
				<funder ref="#_rAz52YE">
					<orgName type="full">NASA</orgName>
				</funder>
				<funder ref="#_CgzMqG3">
					<orgName type="full">National Institutes of Health</orgName>
					<orgName type="abbreviated">NIH</orgName>
				</funder>
			</titleStmt>
			<publicationStmt>
				<publisher>Bioscientifica</publisher>
				<availability  status="unknown">
					<licence/>
				</availability>
				<date type="published" when="2018-03-01">2018 March 01.</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Kenneth</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Carmen</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Adam</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Biostatistics Program</orgName>
								<orgName type="department" key="dep2">School of Biological and Population Health Sciences</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Russell</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Healthy Aging Research</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><roleName>Ph.D</roleName><forename type="first">Urszula</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
							<email>urszula.iwaniec@oregonstate.edu</email>
							<affiliation key="aff0">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
							<affiliation key="aff2">
								<orgName type="department">Center for Healthy Aging Research</orgName>
								<orgName type="laboratory">Skeletal Biology Laboratory</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
									<country key="US">USA</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="department">School of Biological and Population Health Sciences</orgName>
								<orgName type="institution">Oregon State University</orgName>
								<address>
									<postCode>97331</postCode>
									<settlement>Corvallis</settlement>
									<region>OR</region>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Leptin stimulates bone formation in ob/ob mice at doses having minimal impact on energy metabolism</title>
					</analytic>
					<monogr>
						<title level="j" type="main">Journal of Endocrinology</title>
						<idno type="ISSN">0022-0795</idno>
						<idno type="eISSN">1479-6805</idno>
						<imprint>
							<publisher>Bioscientifica</publisher>
							<biblScope unit="volume">232</biblScope>
							<biblScope unit="issue">3</biblScope>
							<biblScope unit="page" from="461" to="474"/>
							<date type="published" when="2018-03-01">2018 March 01.</date>
						</imprint>
					</monogr>
					<idno type="MD5">3F36050D15449BCC127C12F049A9BB11</idno>
					<idno type="DOI">10.1530/joe-16-0484</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-10-04T11:38+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=0, consolidateHeader=1, consolidateFunders=0, includeRawAffiliations=false, includeRawCitations=false, includeRawCopyrights=false, generateTeiIds=false, generateTeiCoordinates=[], sentenceSegmentation=false, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>KAP, AJB, RTT KAP, CPW, and RTT KAP, AJB, CPW, RTT, and UTI animal model</term>
					<term>bone formation</term>
					<term>osteoblasts</term>
					<term>neuroendocrine</term>
					<term>bone histomorphometry</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p>Leptin, the protein product of the ob gene, is essential for normal bone growth, maturation, and turnover. Peripheral actions of leptin occur at lower serum levels of the hormone than central actions because entry of leptin into the central nervous system (CNS) is limited due to its saturable transport across the blood brain barrier (BBB). We performed a study in mice to model the impact of leptin production associated with different levels of adiposity on bone formation and compared the response with well-established centrally-mediated actions of the hormone on energy metabolism. Leptin was infused (0, 4, 12, 40, 140, or 400 ng/h) for 12 days into 6-week-old female ob/ob mice (n=8/group) using sc implanted osmotic pumps. Treatment resulted in a doseassociated increase in serum leptin. Bone formation parameters were increased at EC 50 infusion rates of 7-17 ng/h whereas higher levels (EC 50 , 40-80 ng/h) were required to similarly impact indices of energy metabolism. We then analyzed gene expression in tibia and hypothalamus at dose rates of 0, 12 and 140 ng/h; the latter dose resulted in serum leptin levels similar to WT mice. Infusion with 12 ng/h leptin increased expression of genes associated with Jak/Stat signaling and bone formation in tibia with minimal effect on Jak/Stat signaling and neurotransmitters in hypothalamus. The results suggest that leptin acts peripherally to couple bone acquisition to energy availability and that limited transport across the BBB insures that the growth promoting actions of peripheral leptin are not curtailed by the hormone's CNS-mediated anorexigenic actions.</p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Introduction</head><p>Leptin, the protein product of the ob gene, is produced primarily by adipocytes and secreted into the vascular circulation in proportion to fat stored in adipose depots <ref type="bibr" target="#b30">(Jequier 2002)</ref>. Leptin receptors are widely expressed in peripheral tissues and the adipokine can act directly on a variety of cells to regulate their differentiation and metabolism <ref type="bibr" target="#b0">(Anubhuti and Arora 2008;</ref><ref type="bibr" target="#b43">Sainz, et al. 2015)</ref>. Additionally, the hormone is transported across the blood brain barrier (BBB) where it functions to regulate appetite and energy expenditure <ref type="bibr" target="#b1">(Banks, et al. 1996)</ref>.</p><p>Leptin signaling is required for normal bone growth in rodents. Absence of leptin signaling in leptin-deficient ob/ob mice or leptin receptor-deficient db/db mice and fa/fa rats results in a plethora of skeletal abnormalities, the most common of which are reduced bone length, bone-and bone compartment-specific alterations in cancellous bone volume fraction, reduced cortical thickness, and reduced cortical and total bone mass <ref type="bibr" target="#b11">(Ealey, et al. 2006;</ref><ref type="bibr" target="#b14">Gat-Yablonski and Phillip 2008;</ref><ref type="bibr" target="#b23">Hamrick, et al. 2004;</ref><ref type="bibr" target="#b56">Williams, et al. 2011)</ref>. At the cellular level, these abnormalities are associated with impaired endochondral ossification, lower bone formation due to reductions in osteoblast number and activity, and mild osteopetrosis due to impaired osteoclast function <ref type="bibr" target="#b34">(Kishida, et al. 2005;</ref><ref type="bibr" target="#b50">Turner, et al. 2013)</ref>. Not surprisingly, bone mechanical properties are often reduced and bone regeneration impaired in leptin signaling-deficient rodents <ref type="bibr" target="#b21">(Hamann, et al. 2014;</ref><ref type="bibr" target="#b22">Hamann, et al. 2013;</ref><ref type="bibr" target="#b33">Khan, et al. 2013;</ref><ref type="bibr" target="#b41">Picke, et al. 2015;</ref><ref type="bibr" target="#b54">Wallner, et al. 2015)</ref>.</p><p>Leptin receptors are expressed on many mesenchymal and hematopoietic lineage-derived cells residing in bone and cartilage, suggesting that the hormone may act locally to regulate skeletal metabolism. However, leptin-deficient rodents also develop morbid obesity, reduced core body temperature, elevated corticosteroid levels, insulin resistance, and hypogonadism, each of which, alone or in combination, may influence bone metabolism through leptinindependent pathways <ref type="bibr">(Iwaniec, et al. 2009;</ref><ref type="bibr" target="#b37">Lindstrom 2007;</ref><ref type="bibr" target="#b44">Saito and Bray 1983)</ref>. Indeed, equalization of weight gain, blood glucose levels, and energy balance of ob/ob to that of wild type (WT) mice worsened the skeletal phenotype associated with leptin deficiency <ref type="bibr" target="#b51">(Turner, et al. 2014)</ref>. Thus, the skeletal phenotype of leptin-deficient mice is likely due to perturbation in multiple pathways. Understanding the precise role of leptin in regulating bone growth and maturation is important because in humans low leptin levels are associated with low peak bone mass which in turn is associated with increased fracture risk <ref type="bibr" target="#b12">(Farr and Khosla 2015)</ref>.</p><p>A saturable transport mechanism is required for leptin to cross the BBB <ref type="bibr" target="#b1">(Banks et al. 1996)</ref>. As a consequence, leptin levels in peripheral circulation are typically over 10 times greater than the levels within the brain. The existence of this concentration gradient suggests higher occupancy of leptin receptor in peripheral tissues than brain <ref type="bibr" target="#b45">(Scatchard 1948)</ref>. We therefore determined the relative responsiveness of bone and other target tissues to circulating leptin levels. This was accomplished by performing a 12-day dose-response study in which physiologically relevant concentrations of the hormone were continuously infused into ob/ob mice using sc implanted osmotic pumps to model leptin production by adipose tissue.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Materials and Methods</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Experimental design</head><p>Six-week-old female ob/ob and homozygous WT (+/+) littermate mice were purchased from Jackson Laboratory (Bar Harbor, ME, USA). The animals were placed at thermoneutral temperature (32°C) immediately upon arrival at Oregon State University and maintained singly housed on a 12 h light:12 h dark cycle. Thermoneutral housing was used to avoid mild cold stress associated with standard room temperature <ref type="bibr" target="#b28">(Iwaniec, et al. 2016;</ref><ref type="bibr" target="#b35">Kokolus, et al. 2013</ref>). The ob/ob mice were randomized by weight into one of 6 treatment groups (n=8 mice/group) with leptin delivered at a dose rate of 0 (vehicle), 0.1, 0.3, 1.0, 3.5, or 10 μg/d (equivalent to 0, 4, 12, 40, 140 or 400 ng/h or approximately equivalent to 0, 2.7, 8.2, 27, 96, and 274 μg/kg/d at treatment initiation based on a mean starting ob/ob mouse weight of 36.5 g). Vehicle (20 mM Tris-HCL, Invitrogen, Carlsbad, CA) or mouse leptin (498-OB-05M, R&amp;D Systems, Minneapolis, MN) was infused using sc-implanted osmotic pumps (Alzet Model 1002, Durect Corporation, Cupertino, CA) for the 12-day duration of study. WT mice (n=9) were untreated. The experimental protocol was approved by the Institutional Animal Care and Use Committee in accordance with the NIH Guide for the Care and Use of Laboratory Animals. Food (Teklad 8604, Harlen Laboratories, Indianapolis, IN) and water were provided ad libitum to all animals. Body weight was recorded on days -2, 0 (pump implantation), 3, 6, 8, 10, and 12. Food records were started on day -2, one day after arrival/placement into thermoneutral housing. Food intake was recorded on days -1, 3, 6, 10, and 12. Fluorochromes were administered at 9 (declomycin), 4 (calcein) and 1 (calcein) d prior to necropsy to label mineralizing bone and cartilage as described <ref type="bibr" target="#b51">(Turner et al. 2014)</ref>. Mice were fasted overnight prior to necropsy, bled by cardiac puncture, and glucose measured using a glucometer <ref type="bibr">(Life Scan, Inc., Milpitas, CA)</ref>. Uteri and abdominal white adipose tissue (WAT) were excised and weighed. Femora were removed, fixed for 24h in 10% buffered formalin and stored in 70% ethanol for microcomputed tomography and histomorphometric analysis. Tibiae and hypothalami were removed, frozen in liquid nitrogen, and stored at -80ºC for mRNA analysis.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Serum chemistry</head><p>Serum leptin was measured using Mouse Leptin Quantikine ELISA Kit (R&amp;D Systems, Minneapolis, MN), serum osteocalcin was measured using Mouse Gla-Osteocalcin High Sensitive EIA Kit (Clontech, Mountain View, CA), and serum CTx-1 was measured using Mouse C terminal telopeptides of type I collagen (CTx-1) ELISA kit (Life Sciences Advanced Technologies, St. Petersburg, FL) according to the respective manufacturer's protocol. Intra-assay coefficient of variation (CV) for all ELISA assays were within the manufactures' reported CVs of ≤ 5% for osteocalcin and leptin and ≤ 10% for CTx-1.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Microcomputed Tomography</head><p>Microcomputed tomography (μCT) was used for nondestructive 3-dimensional evaluation of cancellous bone volume and architecture. Femora were scanned in 70% ethanol using a Scanco μCT40 scanner (Scanco Medical AG, Basserdorf, Switzerland) at a voxel size of 12 x 12 x 12 μm (55 kV p x-ray voltage, 145 μA intensity, and 200 ms integration time). Filtering parameters sigma and support were set to 0.8 and 1, respectively. Bone segmentation was conducted at a threshold of 245 (scale, 0-1000) determined empirically. Forty-two consecutive slices (504 μm) of cancellous bone, 45 slices (540 μm) proximal to the growth plate, were evaluated in the distal femur metaphysis. Direct cancellous bone measurements included cancellous bone volume fraction (bone volume/tissue volume, %), trabecular number (mm -1 ), and trabecular thickness (μm).</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Histomorphometry</head><p>The methods used to measure longitudinal bone growth and static and dynamic bone histomorphometry have been described <ref type="bibr" target="#b29">(Iwaniec, et al. 2008)</ref> with modifications for mice <ref type="bibr" target="#b50">(Turner et al. 2013)</ref>. In brief, distal femora were dehydrated in a graded series of ethanol and xylene, and embedded undecalcified in modified methyl methacrylate. Longitudinal sections (4 μm thick) were cut with a vertical bed microtome (Leica 2065) and affixed to slides precoated with 1% gelatin solution. One section/animal was stained for tartrate resistant acid phosphatase and counterstained with toluidine blue (Sigma, St Louis) and used for cellbased measurements. One section/animal was mounted unstained for measurement of fluorochrome labels. All data were collected using the OsteoMeasure System (OsteoMetrics, Inc., Atlanta, GA). The sampling site for the distal femoral metaphysis was located 0.25-1.25 mm proximal to the growth plate.</p><p>Cell-based measurements included osteoblast perimeter (osteoblast perimeter/bone perimeter, %) and osteoclast perimeter (osteoclast perimeter/bone perimeter, %). Fluorochrome-based measurements of bone formation included mineralizing perimeter (mineralizing perimeter/bone perimeter: cancellous bone perimeter covered with double plus half single label normalized to bone perimeter, %), 2) mineral apposition rate (the distance between two fluorochrome markers that comprise a double label divided by the 3 day interlabel interval, μm/d), 3) bone formation rate (bone formation rate/bone perimeter: calculated by multiplying mineralizing perimeter by mineral apposition rate normalized to bone perimeter, μm 2 /μm/y), and longitudinal bone growth (distance between the growth plate-metaphyseal junction and the declomycin label deposited in the primary spongiosa divided by the 9 day interval between label administration and necropsy, μm/day). All bone histomorphometric data are reported using standard 2-dimensional nomenclature <ref type="bibr" target="#b9">(Dempster, et al. 2013)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>EC 50 Calculation</head><p>The EC 50 for each response variable was the calculated dose required to achieve ½ of the maximum observed response.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Gene expression</head><p>Total RNA from tibia and hypothalamus were isolated from 5-6 mice/group and individually analyzed. Tibiae were pulverized with a mortar and pestle in liquid nitrogen and further homogenized in Trizol (Life Technologies, Grand Island, NY). Hypothalamus was directly homogenized in Trizol. Total RNA was isolated according to the manufacturer's protocol, and mRNA was reverse transcribed into cDNA using SuperScript III First-Strand Synthesis SuperMix for qRT-PCR (Life Technologies). The expression of 84 genes related to JAK/ STAT signaling was determined for hypothalamus and bone using the mouse JAK/STAT Signaling Pathway RT 2 Profiler PCR Array (PAMM-039Y) according to the manufacturer's protocol (Qiagen, Valencia, CA). The expression of 84 genes related to neurotransmitter receptors in hypothalamus and 84 genes related to bone formation and bone resorption in tibia was determined using the Mouse "Neurotransmitter Receptors" RT 2 Profiler PCR Array (PAMM-060Z) and Mouse "Osteoporosis" RT 2 Profiler PCR Array (PAMM-170Z), respectively. Gene expression in hypothalamus was normalized to Hsp90ab1 and in tibia was normalized to GAPDH. Relative quantification was determined (ΔΔCt method) using RT 2 Profiler PCR Array Data Analysis software version 3.5 (Qiagen). Fold-change was calculated using vehicle-treated ob/ob mice as the control. Venn diagrams comparing the overlap of significantly (P &lt; 0.05) differentially expressed genes with a ≥ 1.2-fold differential expression in ob/ob mice treated with 12 ng/h leptin and ob/ob mice treated with 140 ng/h leptin compared to ob/ob mice treated with vehicle were generated with BioVenn <ref type="bibr" target="#b25">(Hulsen, et al. 2008)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical Analysis</head><p>Mean responses were compared between six groups (vehicle control group and groups receiving leptin at 4, 12, 40, 140 or 400 ng/h) using separate one-way analysis of variance (ANOVA). A modified F test was used when the assumption of equal variance was violated, with Welch's two-sample t-test used for pairwise comparisons <ref type="bibr" target="#b55">(Welch 1955)</ref>. The Kruskal-Wallis nonparametric test was used when only the normality assumption was violated, in which case the Wilcoxon-Mann-Whitney test was used for pairwise comparisons. The required conditions for valid use of ANOVA were assessed using Levene's test for homogeneity of variance, plots of residuals versus fitted values, normal quantile plots, and the Anderson-Darling test of normality. The Benjamini and Hochberg method for maintaining the false discovery rate at 5% was used to adjust for multiple comparisons <ref type="bibr" target="#b4">(Benjamini and Hochberg 1995)</ref>. Mean food intake (g/d) for the ob/ob vehicle group was compared to the five ob/ob groups that received leptin (4, 12, 40, 140, and 400 ng/h) using longitudinal data collected one day prior to pump implantation (-1) and on days 3, 6, 10, and 12 post implantation. In addition, a comparison of mean body weight (g) for these groups was made using longitudinal data collected on days -2, 0 (pump implantation), and 3, 6, 8, 10, 12 post implantation. Multivariate linear regression models were fit using predictor variables for leptin group, time (treated as categorical and continuous), and the group by time interaction with different covariance structures, namely independence, unstructured, and compound symmetric and autoregressive of order 1 with equal and unequal variance over time. Linear mixed models with random intercepts and slopes were also considered. Model selection was performed using the Bayesian information criterion and likelihood ratio tests. Data analysis was performed using R version 2.12 <ref type="bibr" target="#b48">(Team 2015)</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Results</head><p>The dose-response effects of leptin administration on serum leptin and indices related to energy metabolism in ob/ob mice are shown in Fig. <ref type="figure">1</ref>. Leptin was consistently detected in serum of ob/ob mice when infused at 40 ng/h, achieved values similar to WT mice at 140 ng/h, and was elevated compared to WT mice at 400 ng/h (Fig. <ref type="figure">1A</ref>). Thermogenesis is regulated by a combination of sensory and sympathetic inputs while appetite and pituitary hormone release (e.g., GnRH) are regulated by leptin through a hypothalamic relay. We therefore measured UCP-1 gene expression (Fig. <ref type="figure">1B</ref>) as an index of non-shivering thermogenesis, and food intake (Fig. <ref type="figure">1C</ref> and <ref type="figure">D</ref>) as an index of appetite. We measured body weight (Fig. <ref type="figure">1E</ref>), abdominal white adipose tissue weight (Fig. <ref type="figure">1F</ref>), and blood glucose (Fig. <ref type="figure">1G</ref>) as additional endpoints related to energy metabolism. Finally, we measured uterine weight (Fig. <ref type="figure">1H</ref>) as an index of GnRH release <ref type="bibr" target="#b16">(Gibson, et al. 1994)</ref>. UCP-1 gene expression in BAT, food intake over the treatment interval, and body weight change over the treatment interval were significantly affected at a leptin dose of 12 ng/h, corresponding to serum leptin at or below the detection limit of the immunoassay (0.5 ng/ml), whereas changes in other endpoints, including abdominal WAT weight, blood glucose levels, and uterine weight, required 40 ng/h or higher dose rates before achieving statistical significance. As expected <ref type="bibr" target="#b28">(Iwaniec et al. 2016)</ref>, transfer of mice from room temperature to thermoneutral housing resulted in a dramatic reduction in food intake (Figure <ref type="figure">1C</ref>), with no impact on body weight in vehicle-treated mice. Depending on endpoint measured, the EC 50 of leptin for indices of energy metabolism required dose rates of 40 -80 ng/h (Figure <ref type="figure" target="#fig_1">2A</ref>), corresponding to serum leptin levels between 2 and 6 ng/ml. Specifically, the EC 50 was 80 ng/h for UCP-1 gene expression, 53 ng/h for cumulative food intake, 40 ng/h for body weight change, 66 ng/h for WAT weight, 68 ng/h for blood glucose, and 57 ng/h for uterine weight.</p><p>Longitudinal bone growth rate (Fig. <ref type="figure" target="#fig_2">3A</ref>), osteoblast perimeter (Fig. <ref type="figure" target="#fig_2">3B</ref>), mineralizing perimeter (Fig. <ref type="figure" target="#fig_2">3C</ref>), mineral apposition rate (Fig. <ref type="figure" target="#fig_2">3D</ref>), bone formation rate (Fig. <ref type="figure" target="#fig_2">3E</ref>), serum osteocalcin (Fig. <ref type="figure" target="#fig_2">3F</ref>), osteoclast perimeter (Fig. <ref type="figure" target="#fig_2">3G</ref>), and serum CTx-1 (Fig. <ref type="figure" target="#fig_2">3H</ref>) were determined as indices of bone growth and turnover in distal femur metaphysis. Depending upon endpoint measured, positive effects of leptin were first observed for bone growth and formation parameters at rates of 4-12 ng/h. Significant differences in osteoclast perimeter were not detected with treatment, but serum CTx-1 was increased at leptin infusion rates of 140 and 400 ng/h. Representative micrographs illustrating the low dose (12 ng/h) effects of leptin on bone formation are shown in Fig. <ref type="figure" target="#fig_1">2I-J</ref>. The low turnover of cancellous bone in ob/ob mice is illustrated by presence of declomycin label (administered 9 d prior to sacrifice) whereas extensive double calcein label (administered 4 d and 1 d prior to sacrifice) and the absence of declomycin label in ob/ob mice treated with leptin is indicative of high turnover <ref type="bibr" target="#b50">(Turner et al. 2013)</ref>. With the exception of trabecular thickness which was increased at and above leptin infusion rates of 40 ng/h (Fig. <ref type="figure">1K</ref>), differences in cancellous bone microarchitecture (bone volume fraction, trabecular number, connectivity density or trabecular spacing) were not detected with treatment (data not shown). This was expected, given the short duration (12 days) of study. Depending on endpoint measured, the EC 50 for leptin on indices of bone formation ranged from 7-25 ng/h (Fig 2B ), corresponding to serum leptin levels of &lt; 1 ng/ml. Specifically, the half maximum response occurred at 25 ng/h for longitudinal bone growth rate, 17 ng/h for osteoblast perimeter, 7 ng/h for mineralizing perimeter, 12 ng/h for mineral apposition rate, 10 ng/h for bone formation rate, 12 ng/h for serum osteocalcin, and 7 ng/h for trabecular thickness. The EC 50 was not determined for osteoclast perimeter because no significant changes were detected.</p><p>To verify the apparent dose-selective actions of leptin on hypothalamus and bone, we profiled changes in gene expression in tibia and hypothalamus in animals receiving leptin at 12 ng/h (a dose rate that increased longitudinal bone growth and bone formation but had minimal effect on energy metabolism) and 140 ng/h (a dose rate that affected both bone and energy metabolism), and compared these to vehicle-treated ob/ob controls using pathwayfocused gene expression PCR arrays. Because leptin binds to its receptor to activate Jak/Stat signaling, we profiled genes related to activation of Jak/Stat signaling in hypothalamus and tibia. Functional outcomes of leptin treatment in hypothalamus and bone include increased neuronal signaling and increased bone growth and turnover, respectively. We therefore analyzed the effects of leptin on the expression of genes involved in neurotransmitter receptors in hypothalamus, and osteoblast and osteoclast differentiation and function in tibia. Differential gene expression was defined as P &lt; 0.05 and a fold change of ≥ 1.2. As shown in the Venn diagrams (Fig. <ref type="figure">4</ref>), leptin infusion at the dose rate of 12 ng/h had minimal effects on either Jak/Stat signaling genes or neurotransmitter receptor genes in hypothalamus (Fig. <ref type="figure">4A</ref> and <ref type="figure">4C</ref>). Only 2 genes and 5 genes, respectively were differentially expressed compared to ob/ob controls. In contrast, there were robust changes in Jak/Stat signaling genes (Fig. <ref type="figure">4B</ref>) and bone cell-related genes (Fig. <ref type="figure">4D</ref>) in tibia. A total of 25 genes involved in Jak/Stat signaling (Fig. <ref type="figure">4B</ref>) and 21 genes involved in osteoblast and osteoclast differentiation and function (Fig. <ref type="figure">4D</ref>) were differentially expressed in the tibia in ob/ob mice infused with leptin at a dose rate of 12 ng/h compared to vehicle-treated ob/ob controls. The 140 ng/h leptin dose resulted in robust changes in gene expression in hypothalamus and further increases in number of differentially expressed genes in tibia. All genes differentially expressed (P &lt; 0.05) in response to leptin in hypothalamus and tibia, regardless of fold change, are identified in Tables <ref type="table" target="#tab_0">1</ref><ref type="table">2</ref><ref type="table">3</ref><ref type="table" target="#tab_1">4</ref>.</p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Discussion</head><p>This study was performed to determine the dose response effects of leptin on bone and energy metabolism. The results demonstrate that leptin acts on the skeleton at dose rates having minimal impact on energy metabolism. Specifically, leptin increased osteoblast perimeter, mineralizing perimeter, and bone formation rate at an infusion rate of 4 ng/h, and mineral apposition rate and longitudinal growth rate at an infusion rate of 12 ng/h. Leptin increased UCP-1 gene expression and decreased food intake and rate of body weight gain at an infusion rate of 12 ng/h. These dose rates (4 and 12 ng/h) resulted in serum leptin levels below or at the detection limit of the serum leptin immunoassay (0.5 ng/ml) and were insufficient to affect uterine weight, cumulative food intake, hyperglycemia, or abdominal WAT weight. Bone formation parameters were increased at EC 50 ranging from 7-17 ng/h whereas higher leptin levels (EC 50 of 40-80 ng/h) were required to similarly impact indices of energy metabolism. Due to the short duration of study, few changes in bone microarchitecture were anticipated or detected. However, consistent with increased bone formation, a significant increase in trabecular thickness was noted in the leptin-treated mice.</p><p>Few studies have investigated the dose-response effects of leptin. However, similar to the current findings, no effects of low sc infusion rates of leptin (&lt;40 ng/h) for 12 days on terminal body weight, fat depots, and uterine weight were reported <ref type="bibr" target="#b24">(Harris, et al. 1998;</ref><ref type="bibr" target="#b49">Trotter-Mayo and Roberts 2008)</ref>. Higher doses (200 ng/h) of sc leptin were shown to be required to reduce body weight in WT mice and even higher doses (500 ng/h) were required to deplete fat stores <ref type="bibr" target="#b20">(Halaas, et al. 1997</ref>).</p><p>The precise mechanisms mediating the physiological actions of leptin on bone are uncertain. Delivery of leptin gene into the hypothalamus of ob/ob mice reversed the skeletal abnormalities in bone architecture associated with leptin deficiency <ref type="bibr" target="#b26">(Iwaniec, et al. 2007</ref>). Also, once daily direct delivery of high concentrations of the hormone into the hypothalamus increased bone formation <ref type="bibr" target="#b3">(Bartell, et al. 2011)</ref>. In contrast, continuous infusion of high concentrations of leptin into the hypothalamus was reported to be antiosteogenic <ref type="bibr" target="#b10">(Ducy, et al. 2000)</ref>. Direct administration of leptin or the leptin gene into the hypothalamus was originally interpreted as evidence that leptin acts indirectly through a hypothalamic relay to regulate bone metabolism <ref type="bibr" target="#b10">(Ducy et al. 2000;</ref><ref type="bibr" target="#b26">Iwaniec et al. 2007;</ref><ref type="bibr">Kalra, et al. 2009;</ref><ref type="bibr" target="#b47">Takeda, et al. 2002)</ref>. However, this conclusion is predicated on intracerebroventricular (icv) leptin remaining within the central nervous system. This assumption is not well supported because there is ample evidence indicating that icv leptin readily enters peripheral circulation. Using tracer methodology, Maness et al. <ref type="bibr" target="#b38">(Maness, et al. 1998</ref>) investigated the fate of leptin after icv administration and found that efflux of leptin from the brain occurred with reabsorption of the cerebrospinal fluid into the blood. Efflux was not saturable and the amount of leptin in peripheral circulation after icv injection actually equaled or exceeded levels seen 20 minutes following iv administration <ref type="bibr" target="#b38">(Maness et al. 1998)</ref>. The authors concluded that icv leptin achieves exposure levels in the brain at least 300 times higher than when delivered iv, but efficient reabsorption of cerebrospinal fluid into the blood introduces leptin into peripheral circulation where the hormone can bind to receptors on target cells. This conclusion is also supported by Trotter-Mayo and Roberts (Trotter-Mayo and Roberts 2008) who compared ip and icv delivery of leptin (8 ng/h) and demonstrated that leptin delivered icv enters peripheral circulation and activates leptin receptors on thymocytes. In similar light, adoptive transfer of leptin-resistant db/db bone marrow into WT mice (db/db→WT) was shown to mimic the effects of leptin deficiency on bone without impacting centrally-mediated actions of leptin on energy metabolism <ref type="bibr" target="#b50">(Turner et al. 2013)</ref>. Importantly, icv leptin dose rates administered to ob/ob mice in bone studies described above have equaled or exceeded the dose rate (8 ng/h) used by Trotter-Mayo and Roberts (Trotter-Mayo and Roberts 2008) and would have resulted in hypothalamic leptin levels unlikely to be achieved physiologically. Thus, the exquisite sensitivity of bone to low blood levels of leptin reported in the current study combined with the knowledge that leptin is transported out of the brain into peripheral circulation following icv infusion question whether the skeletal response to icv leptin is entirely due to actions mediated centrally.</p><p>The long form of the leptin receptor (LepRb) belongs to gp130 family of cytokine receptors and binding of leptin to LepRb activates the Jak/Stat intracellular signaling pathways <ref type="bibr">(Nanjappa V 2011)</ref>. The robust differential expression of genes related to Jak/Stat signaling in bone following sc administration of low dose leptin (12 ng/h) provides strong evidence that leptin acts directly on one or more target cells in mouse long bones. Although the present study does not identify the precise leptin target cells in bone, osteoblast lineage cells are candidates. Osteoblasts are reported to express leptin receptors and analysis of the osteoblast transcriptome supports a role for peripheral leptin signaling in bone cell function <ref type="bibr" target="#b18">(Grundberg, et al. 2008</ref>). Leptin has also been shown to activate multiple pathways, including Jak/Stat, in cultured osteoblast lineage cells <ref type="bibr" target="#b6">(Burguera, et al. 2006;</ref><ref type="bibr" target="#b17">Gordeladze, et al. 2002;</ref><ref type="bibr" target="#b36">Lee, et al. 2002;</ref><ref type="bibr" target="#b57">Yang, et al. 2014)</ref>.</p><p>In marked contrast to its actions on gene expression in tibia, leptin at 12 ng/h had minimal effects on genes related to Jak/Stat signaling in hypothalamus. However, higher levels of leptin (140 ng/h; resulting in serum leptin levels in ob/ob mice similar to that of WT mice) were associated with robust changes in gene expression in hypothalamus. In addition to the differential dose response, there was relatively little overlap in the genes regulated in tibia and hypothalamus and when there was overlap (e.g., Smads 1, 2 and 5), the genes were often differentially expressed in opposite directions. Taken together, these findings indicate that leptin targets Jak/Stat signaling in tibia as well as hypothalamus.</p><p>In the present study, sc leptin administration resulted in increased mRNA levels for bone and cartilage matrix proteins in tibia of ob/ob mice, a finding in agreement with the increase in bone formation and longitudinal bone growth and in agreement with previous studies evaluating bone metabolism in ob/ob mice <ref type="bibr" target="#b3">(Bartell et al. 2011;</ref><ref type="bibr" target="#b34">Kishida et al. 2005;</ref><ref type="bibr" target="#b51">Turner et al. 2014)</ref>. Additionally, a very low level of sc leptin replacement (12 ng/h) in ob/ob mice increased expression of genes related to BMP signaling, including Bmp 7 and Smad 1, 2, 3, 4 and 5. We have previously shown that leptin deficiency results in altered expression of TGFβ 1 , β 2 and β 3 , BMP 2, 3 and 6, and BMPr1a <ref type="bibr" target="#b51">(Turner et al. 2014)</ref>. Although Stat3mediated activation of BMP/Smad signaling has been demonstrated in neural stem cells <ref type="bibr" target="#b13">(Fukuda, et al. 2007</ref>) and BMPr1 was shown to regulate development of hypothalamic circuits critical for feeding behavior <ref type="bibr" target="#b40">(Peng, et al. 2012)</ref>, leptin-mediated BMP signaling in bone has received little attention.</p><p>After crossing the BBB, leptin binds to and activates receptors residing on POMC and AgRP/NPY-expressing neurons in the arcuate nucleus of the hypothalamus. POMC neurons are anorexigenic and stimulated by leptin while AgRP/NPY neurons are orexigenic and inhibited by leptin. These arcuate nucleus neurons project directly to nuclei in several sites which play important roles in leptin-mediated regulation of feeding behavior <ref type="bibr" target="#b7">(Cone 2005;</ref><ref type="bibr" target="#b15">Gautron and Elmquist 2011)</ref>. The present study demonstrates that leptin modulates expression of a group of genes related to neurotransmission in the hypothalamus. Particularly notable were the increases in expression in dopamine receptor D5 (Drd5), bombesin receptor subtype 3 (Brs3), alpha-1D adrenergic receptor (Adra1d), serotonin receptor 2A (Htr2a), and serotonin receptor 4 (Htr4). However, these changes were not apparent at leptin levels that increased longitudinal bone growth and osteoblast number and activity.</p><p>Bone resorption is reduced in ob/ob mice, as reflected by delayed skeletal maturation (delayed replacement of calcified cartilage by bone), prolonged retention of fluorochrome labels deposited into mineralizing bone, and low serum levels of CTx-1, a biochemical marker of global bone resorption <ref type="bibr" target="#b50">(Turner et al. 2013;</ref><ref type="bibr" target="#b51">Turner et al. 2014</ref>). Osteoclast perimeter is not reduced, suggesting that leptin deficiency impairs osteoclast activity rather than reducing the number of osteoclasts <ref type="bibr" target="#b51">(Turner et al. 2014)</ref>. Compared to age-matched WT mice, serum CTx-1 levels in the present study were very low in leptin-deficient ob/ob mice.</p><p>Leptin treatment increased serum CTx-1 but only at higher dose rates, which suggests that the positive effects of physiological doses of leptin on bone formation are not coupled to the hormone's actions to increase bone resorption.</p><p>Leptin acts through the CNS as a permissive factor for release of the neurohormone GnRH from the pituitary <ref type="bibr" target="#b2">(Barkan, et al. 2005)</ref>, which in turn stimulates an increase in estrogen secretion from the ovaries. Estrogen deficiency induced by hypogonadism typically results in increases in bone elongation and turnover in growing rodents <ref type="bibr" target="#b52">(Turner, et al. 1994</ref>), a response that may be antagonized by leptin. Near normalization of ovarian hormone production, as ascertained by increased uterine weight, corresponded to serum leptin levels comparable to those found in WT mice and was associated with plateauing of leptin-induced increases in indices of bone growth and turnover. Additional research will be necessary to determine whether the increased estrogen levels act to oppose the stimulatory effects of leptin.</p><p>Diabetes is closely associated with morbid obesity which may be due, in part, to development of leptin resistance <ref type="bibr" target="#b19">(Gunnarsson 1983;</ref><ref type="bibr" target="#b32">Khan, et al. 2001;</ref><ref type="bibr" target="#b46">Schwartz, et al. 1996)</ref>. Diabetes is also associated with decreased bone turnover <ref type="bibr" target="#b42">(Pietschmann, et al. 2010</ref>). In the present study, performed in mice that are both leptin-deficient and diabetic, bone formation was increased at leptin levels having minimal impact on blood glucose levels. ob/ob mice and leptin receptor-deficient db/db mice and fa/fa rats are often used as models for type 2 diabetes. The findings of the present study agree with prior work suggesting that the low bone formation rate in these models is due to leptin signaling deficiency and not diabetes per se <ref type="bibr" target="#b51">(Turner et al. 2014)</ref>.</p><p>Leptin can increase UCP-1 by multiple mechanisms. The increased UCP-1 mRNA level in BAT induced by leptin in the present study is in agreement with prior studies <ref type="bibr" target="#b8">(Cusin, et al. 1998;</ref><ref type="bibr" target="#b53">Ukropec, et al. 2006</ref>) and suggests that a combination of reduced energy intake and increased thermogenesis contributed to the dose-response effects of leptin to reduce weight gain. The importance of increased thermogenesis is consistent with studies where hypothalamic leptin gene therapy was shown to induce weight loss and maintain lower body weight in ob/ob mice and normal rodents with mild or no hypophagia <ref type="bibr">(Boghossian, et al. 2007;</ref><ref type="bibr" target="#b31">Kalra et al. 2009)</ref>.</p><p>In summary, we interpret the above as evidence that osteoblasts and growth plate cartilage cells are exquisitely sensitive to low circulating levels of leptin. The present findings, combined with results from earlier studies investigating adoptive transfer of bone marrow cells from leptin receptor-deficient db/db mice→WT mice, strongly support the hypothesis that bone formation is positively regulated by leptin through peripheral signaling. The saturable transport system, which limits delivery of leptin from the hormone's origin in peripheral adipose tissue to the hypothalamus, may function to guarantee that adequate energy is available for important anabolic processes such as bone growth and turnover and that these actions are dissociable from the actions of the hormone to reduce appetite and increase thermogenesis. Such a mechanism would serve to insure optimal energy availability for anabolic processes to proceed to support adequate growth. Effects of 12 days of sc leptin infusion on serum leptin (A), uncoupling protein-1 (UCP-1) gene expression in brown adipose tissue (BAT) (B), food intake over duration of treatment (C), cumulative food intake (D), body weight over duration of treatment (E), abdominal white adipose tissue (WAT) weight (F), blood glucose (G) and uterine weight (H) in female ob/ob mice (n=8/group). Please note the expected dramatic decrease in food intake in ob/ob mice associated with transfer from room temperature to thermoneutral housing <ref type="bibr" target="#b28">(Iwaniec et al. 2016)</ref>. Data are mean ± SE. a Different from vehicle-treated ob/ob mice (ob/ob), P&lt;0.05.</p><p>WT is shown as a reference group.  K. Data are mean ± SE. a Different from vehicle-treated ob/ob mice (ob/ob 0), P&lt;0.05. WT is shown as a reference group. Venn diagrams showing the number of genes in hypothalamus (A and C) and tibia (B and D) that were differentially expressed (meeting criteria of p &lt; 0.05 and fold-change of ≥ 1.2) in ob/ob mice (n=5) treated with 12 ng/h leptin (light gray) and ob/ob mice (n=5) treated with 140 ng/h leptin (dark gray) compared to ob/ob mice treated with vehicle (n=6). RT 2 Profiler PCR Arrays were used to quantify expression of transcripts associated with JAK/STAT signaling (A and B), neurotransmitter receptors (C), and genes related to osteoblast and osteoclast differentiation and function (D). Please note the paucity of differentially expressed genes in the hypothalamus compared to tibia in mice infused with leptin at a dose rate of 12 ng/h (2 versus 25 for Jak/Stat signaling and 5 versus 21 for neurotransmitter/bone metabolism). Also note the increases in differentially expressed genes, particularly in hypothalamus, in mice infused with leptin at a dose rate of 140 ng/h. The higher dose rate results in blood leptin levels in ob/ob mice similar to WT mice.   Expressed Genes ob/ob+12 ng/h leptin vs. ob/ob+veh (n=23 genes) ob/ob+140 ng/h leptin vs. ob/ob+veh (n=35 genes) Symbol</p><p>Fold Change P &lt; Symbol Fold Change P &lt; Alox12 -1.2 0.019 Alox12 -1.3 0.042 Alpl 1.4 0.004 Alpl 1.7 0.001 Bglap 1.9 0.001 Bglap 3.0 0.000 Bmp7 1.2 0.009 Bmp7 1.3 0.012 Calcr 2.2 0.007 Calcr 2.2 0.017 Cd40 1.4 0.000 Car2 -3.8 0.000 Col1a1 1.5 0.015 Cd40 2.7 0.000 Col1a2 1.4 0.032 Cnr2 1.6 0.006 Crtap 1.1 0.030 Col1a1 1.7 0.011 Il6ra -1.3 0.003 Col1a2 1.6 0.007 Lepre1 1.3 0.003 Comt -1.4 0.002 Ltbp2 1.2 0.009 Dbp 1.8 0.002 Mmp2 1.4 0.012 Dkk1 1.3 0.038 Npy 1.5 0.025 Enpp1 -1.2 0.004 Nr3c1 1.2 0.018 Esr1 1.2 0.022 Plod2 1.4 0.009 Il15 1.4 0.019 Pth1r 1.3 0.003 Il6ra -1.3 0.018 Sfrp4 1.4 0.002 Itga1 1.1 0.040 Sparc 1.4 0.010 Lepre1 1.5 0.000 Stat1 1.2 0.003 Lrp5 1.3 0.000 Timp2 1.1 0.033 Lrp6 1.2 0.014 Tnfaip3 1.3 0.030 Ltbp2 1.6 0.000 Twist1 1.2 0.027 Mmp2 1.4 0.017 Mthfr 1.4 0.008 Nfatc1 1.2 0.002</p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc>Figure 1.</figDesc><graphic coords="15,90.48,62.00,491.04,487.44" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Figure 2 .</head><label>2</label><figDesc>Figure 2. The apparent half maximum effects (EC 50 ) of leptin on indices of energy metabolism (A) and bone formation (B). Depending on endpoint measured, the half maximum effects of leptin on indices of energy metabolism were detected at dose rates of 40-80 ng/h whereas the half maximum effects of leptin on indices of bone formation were detected at dose rates of 7-25 ng/h. The vertical dotted lines indicate the range in EC 50 .</figDesc><graphic coords="16,212.52,62.00,246.96,308.34" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 3 .</head><label>3</label><figDesc>Figure 3. Effects of 12 days of sc leptin infusion on longitudinal bone growth (A), indices of bone formation consisting of osteoblast perimeter (B), mineralizing perimeter (C), mineral apposition rate (D), bone formation rate (E), and serum osteocalcin (F), and indices of bone resorption consisting of osteoclast perimeter (G) and serum CTx-1 (H) in female ob/ob mice (n=8/group). Representative photomicrographs illustrating differences in fluorochrome labeling in ob/ob mice treated with vehicle (I) and ob/ob mice infused with 12 ng/h leptin (J). Effects of leptin on trabecular thickness, an index of bone microarchitecture, is shown in</figDesc><graphic coords="17,118.56,62.00,434.88,491.49" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><figDesc>Figure 4.</figDesc><graphic coords="19,100.20,62.00,471.59,491.76" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><figDesc>ng/h leptin vs. ob/ob+veh (n=3 genes) ob/ob+140 ng/h leptin vs. ob/ob+veh (and 5 mice in vehicle, 12 ng/h leptin, and 140 ng/h leptin group, respectively. ng/h leptin vs. ob/ob+veh (n=30 genes) ob/ob+140 ng/h leptin vs. ob/ob+veh (and 5 mice in vehicle, 12 ng/h leptin, and 140 ng/h leptin group, respectively. ng/h leptin vs. ob/ob+veh (n=6 genes) ob/ob+140 ng/h leptin vs. ob/ob+veh (and 5 mice in vehicle, 12 ng/h leptin, and 140 ng/h leptin group, respectively.</figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc>Hypothalamus Jak/Stat signaling array showing significant changes for genes in ob/ob mice administered 12 ng/h or 140 ng/h leptin compared to</figDesc><table><row><cell>ob/ob</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_1"><head>Table 4</head><label>4</label><figDesc>Tibia osteoporosis array showing significant changes for genes in ob/ob mice administered 12 ng/h or 140 ng/h leptin compared to ob/ob mice administered vehicle (0 ng/h leptin).</figDesc><table><row><cell>Differentially</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot" xml:id="foot_0"><p>J Endocrinol. Author manuscript; available in PMC 2018 March 01.</p></note>
		</body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>Funding: This work was supported by grants from the <rs type="funder">NIH</rs> (<rs type="grantNumber">AR060913</rs>), <rs type="funder">NASA</rs> (<rs type="grantNumber">NNX12AL24</rs>), and <rs type="funder">USDA</rs> (<rs type="grantNumber">38420-17804</rs>).</p></div>
			</div>
			<listOrg type="funding">
				<org type="funding" xml:id="_CgzMqG3">
					<idno type="grant-number">AR060913</idno>
				</org>
				<org type="funding" xml:id="_rAz52YE">
					<idno type="grant-number">NNX12AL24</idno>
				</org>
				<org type="funding" xml:id="_vQyhKBB">
					<idno type="grant-number">38420-17804</idno>
				</org>
			</listOrg>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Manuscript</head><p>Philbrick et al.</p><p>Page 22    </p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Leptin and its metabolic interactions: an update</title>
		<author>
			<persName><surname>Anubhuti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arora</surname></persName>
		</author>
		<idno type="PMID">18284436</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes Obes Metab</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="973" to="993" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Leptin enters the brain by a saturable system independent of insulin</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Banks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kastin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Jaspan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Maness</surname></persName>
		</author>
		<idno type="PMID">8801538</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="305" to="311" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Leptin induces ovulation in GnRHdeficient mice</title>
		<author>
			<persName><forename type="first">D</forename><surname>Barkan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Hurgin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Dekel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Amsterdam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rubinstein</surname></persName>
		</author>
		<idno type="PMID">15629898</idno>
	</analytic>
	<monogr>
		<title level="j">FASEB J</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="133" to="135" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Bartell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Rayalam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ambati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Gaddam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Hartzell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hamrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">X</forename><surname>She</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Della-Fera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Baile</surname></persName>
		</author>
		<idno type="PMID">21520275</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1710" to="1720" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Controlling the false discovery rate: a practical and powerful approach to multiple testing</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Benjamini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hochberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J R Statist Soc B</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="289" to="300" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Leptin gene transfer in the hypothalamus enhances longevity in adult monogenic mutant mice in the absence of circulating leptin</title>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ueno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">17011078</idno>
	</analytic>
	<monogr>
		<title level="j">Neurobiol Aging</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1594" to="1604" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Leptin increases proliferation of human steosarcoma cells through activation of PI(3)-K and MAPK pathways</title>
		<author>
			<persName><forename type="first">B</forename><surname>Burguera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Brunetto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Garcia-Ocana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Teijeiro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Esplen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Couce</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zhao</surname></persName>
		</author>
		<idno type="PMID">17072262</idno>
	</analytic>
	<monogr>
		<title level="j">Med Sci Monit</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="341" to="349" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Anatomy and regulation of the central melanocortin system</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">D</forename><surname>Cone</surname></persName>
		</author>
		<idno type="PMID">15856065</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Neurosci</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="571" to="578" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Chronic central leptin infusion enhances insulin-stimulated glucose metabolism and favors the expression of uncoupling proteins</title>
		<author>
			<persName><forename type="first">I</forename><surname>Cusin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Zakrzewska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Boss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Muzzin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Giacobino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ricquier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jeanrenaud</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Rohner-Jeanrenaud</surname></persName>
		</author>
		<idno type="PMID">9648822</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1014" to="1019" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Standardized nomenclature, symbols, and units for bone histomorphometry: a 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Dempster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Compston</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Drezner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Glorieux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kanis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Malluche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Meunier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Recker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Parfitt</surname></persName>
		</author>
		<idno type="PMID">23197339</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="2" to="17" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass</title>
		<author>
			<persName><forename type="first">P</forename><surname>Ducy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Amling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Priemel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Schilling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Beil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Rueger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karsenty</surname></persName>
		</author>
		<idno type="PMID">10660043</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="197" to="207" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Bone abnormalities in adolescent leptin-deficient mice</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">N</forename><surname>Ealey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Fonseca</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Archer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Ward</surname></persName>
		</author>
		<idno type="PMID">16764953</idno>
	</analytic>
	<monogr>
		<title level="j">Regul Pept</title>
		<imprint>
			<biblScope unit="volume">136</biblScope>
			<biblScope unit="page" from="9" to="13" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Skeletal changes through the lifespan-from growth to senescence</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Farr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khosla</surname></persName>
		</author>
		<idno type="PMID">26032105</idno>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Endocrinol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="513" to="521" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Potentiation of astrogliogenesis by STAT3-mediated activation of bone morphogenetic protein-Smad signaling in neural stem cells</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fukuda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Abematsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yanagisawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kagawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nakashima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Yoshimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Taga</surname></persName>
		</author>
		<idno type="PMID">17452461</idno>
	</analytic>
	<monogr>
		<title level="j">Mol Cell Biol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="4931" to="4937" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Leptin and regulation of linear growth</title>
		<author>
			<persName><forename type="first">G</forename><surname>Gat-Yablonski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Phillip</surname></persName>
		</author>
		<idno type="PMID">18403928</idno>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Clin Nutr Metab Care</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="303" to="308" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Sixteen years and counting: an update on leptin in energy balance</title>
		<author>
			<persName><forename type="first">L</forename><surname>Gautron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Elmquist</surname></persName>
		</author>
		<idno type="PMID">21633176</idno>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2087" to="2093" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Continuous gonadotropin-releasing hormone infusion stimulates dramatic gonadal development in hypogonadal female mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kasowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Dobrjansky</surname></persName>
		</author>
		<idno type="PMID">8167240</idno>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="680" to="685" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: Impact on differentiation markers, apoptosis, and osteoclastic signaling</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">O</forename><surname>Gordeladze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Drevon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Syversen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Reseland</surname></persName>
		</author>
		<idno type="PMID">11968022</idno>
	</analytic>
	<monogr>
		<title level="j">J Cell Biochem</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="825" to="836" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Systematic assessment of the human osteoblast transcriptome in resting and induced primary cells</title>
		<author>
			<persName><forename type="first">E</forename><surname>Grundberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Brandstrom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gurd</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Harmsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kindmark</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ljunggren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mallmin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Nilsson</surname></persName>
		</author>
		<idno type="PMID">18334548</idno>
	</analytic>
	<monogr>
		<title level="j">Physiol Genomics</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="301" to="311" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The pathogenesis of type II diabetes mellitus. A brief survey</title>
		<author>
			<persName><forename type="first">R</forename><surname>Gunnarsson</surname></persName>
		</author>
		<idno type="PMID">6383183</idno>
	</analytic>
	<monogr>
		<title level="j">Ann Clin Res</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="issue">Suppl 37</biblScope>
			<biblScope unit="page" from="6" to="11" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Physiological response to long-term peripheral and central leptin infusion in lean and obese mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Halaas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boozer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Blair-West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fidahusein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Denton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Friedman</surname></persName>
		</author>
		<idno type="PMID">9238071</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">94</biblScope>
			<biblScope unit="page" from="8878" to="8883" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hamann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Picke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Balyura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rauner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Huber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Morlock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Gunther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Bornstein</surname></persName>
		</author>
		<idno type="PMID">24467747</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">155</biblScope>
			<biblScope unit="page" from="1197" to="1206" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus</title>
		<author>
			<persName><forename type="first">C</forename><surname>Hamann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rauner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Hohna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bernhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mettelsiefen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Goettsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">P</forename><surname>Gunther</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stolina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Han</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Asuncion</surname></persName>
		</author>
		<idno type="PMID">23109114</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="627" to="638" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Leptin deficiency produces contrasting phenotypes in bones of the limb and spine</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Hamrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Pennington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Xie</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Isales</surname></persName>
		</author>
		<idno type="PMID">15003785</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="376" to="383" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">A leptin doseresponse study in obese (ob/ob) and lean (+/?) mice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Redmann</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Smagin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Zachwieja</surname></persName>
		</author>
		<idno type="PMID">9421392</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="8" to="19" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">BioVenn -a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams</title>
		<author>
			<persName><forename type="first">T</forename><surname>Hulsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>De Vlieg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Alkema</surname></persName>
		</author>
		<idno type="PMID">18925949</idno>
	</analytic>
	<monogr>
		<title level="j">BMC Genomics</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">488</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Central leptin gene therapy corrects skeletal abnormalities in leptin-deficient ob/ob mice</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Lapke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">17346852</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="1012" to="1019" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Body mass influences cortical bone mass independent of leptin signaling</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Helferich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<idno type="PMID">19095090</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="404" to="412" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Room temperature housing results in premature cancellous bone loss in growing female mice: implications for the mouse as a preclinical model for age-related bone loss</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Kahler-Quesada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Sargent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">E</forename><surname>Demambro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Rosen</surname></persName>
		</author>
		<idno type="PMID">27189604</idno>
	</analytic>
	<monogr>
		<title level="j">Osteoporos Int</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="3091" to="3101" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Histological analysis of bone</title>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Wronski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<idno type="PMID">18369927</idno>
	</analytic>
	<monogr>
		<title level="j">Methods Mol Biol</title>
		<imprint>
			<biblScope unit="volume">447</biblScope>
			<biblScope unit="page" from="325" to="341" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Leptin signaling, adiposity, and energy balance</title>
		<author>
			<persName><forename type="first">E</forename><surname>Jequier</surname></persName>
		</author>
		<idno type="PMID">12079865</idno>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">967</biblScope>
			<biblScope unit="page" from="379" to="388" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Leptin increases osteoblast-specific osteocalcin release through a hypothalamic relay</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Dube</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">19428775</idno>
	</analytic>
	<monogr>
		<title level="j">Peptides</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="967" to="973" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Long-term leptin treatment of ob/ob mice improves glucose-induced insulin secretion</title>
		<author>
			<persName><forename type="first">A</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Narangoda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ahren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Holm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Sundler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Efendic</surname></persName>
		</author>
		<idno type="PMID">11439295</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Obes Relat Metab Disord</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="816" to="821" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The temporal role of leptin within fracture healing and the effect of local application of recombinant leptin on fracture healing</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Duraine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Virk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Rowland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Reddi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Lee</surname></persName>
		</author>
		<idno type="PMID">23287761</idno>
	</analytic>
	<monogr>
		<title level="j">J Orthop Trauma</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="656" to="662" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kishida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hirao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Tamai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nampei</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujimoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Nakase</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Myoui</surname></persName>
		</author>
		<idno type="PMID">16039170</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="607" to="621" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Kokolus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Capitano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Eng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Waight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Hylander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sexton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Hong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Gordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Abrams</surname></persName>
		</author>
		<idno type="PMID">24248371</idno>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="20176" to="20181" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Leptin receptor isoform expression in rat osteoblasts and their functional analysis</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Ju</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>You</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Ko</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kim</surname></persName>
		</author>
		<idno type="PMID">12297277</idno>
	</analytic>
	<monogr>
		<title level="j">FEBS Lett</title>
		<imprint>
			<biblScope unit="volume">528</biblScope>
			<biblScope unit="page" from="43" to="47" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The physiology of obese-hyperglycemic mice [ob/ob mice]</title>
		<author>
			<persName><forename type="first">P</forename><surname>Lindstrom</surname></persName>
		</author>
		<idno type="PMID">17619751</idno>
	</analytic>
	<monogr>
		<title level="j">Scientific World Journal</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="666" to="685" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Fate of leptin after intracerebroventricular injection into the mouse brain</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Maness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Kastin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Banks</surname></persName>
		</author>
		<idno type="PMID">9794465</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">139</biblScope>
			<biblScope unit="page" from="4556" to="4562" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">A Comprehensive Curated Reaction Map of Leptin Signaling Pathway</title>
		<author>
			<persName><forename type="first">Vrr</forename><surname>Nanjappa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Muthusamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Haridas</forename><surname>Nidhina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Harsha1</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Pandey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Anilkumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename></persName>
		</author>
		<author>
			<persName><forename type="first">Keshava</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Proteomics Bioinform</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="184" to="189" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">BMP receptor 1A regulates development of hypothalamic circuits critical for feeding behavior</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">Y</forename><surname>Peng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mukhopadhyay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Jarrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Yoshikawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Kessler</surname></persName>
		</author>
		<idno type="PMID">23197713</idno>
	</analytic>
	<monogr>
		<title level="j">J Neurosci</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="17211" to="17224" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Picke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Gordaliza</forename><surname>Alaguero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">M</forename><surname>Gluer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Salbach-Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Rauner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hofbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Hofbauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
		<idno type="PMID">26055107</idno>
	</analytic>
	<monogr>
		<title level="j">Bone</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="108" to="115" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Diabetes and bone</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pietschmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Patsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Schernthaner</surname></persName>
		</author>
		<idno type="PMID">20711953</idno>
	</analytic>
	<monogr>
		<title level="j">Horm Metab Res</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="763" to="768" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Leptin resistance and diet-induced obesity: central and peripheral actions of leptin</title>
		<author>
			<persName><forename type="first">N</forename><surname>Sainz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Barrenetxe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Moreno-Aliaga</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Martinez</surname></persName>
		</author>
		<idno type="PMID">25497342</idno>
	</analytic>
	<monogr>
		<title level="j">Metabolism</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="35" to="46" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Diurnal rhythm for corticosterone in obese (ob/ob) diabetes (db/db) and goldthioglucose-induced obesity in mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Bray</surname></persName>
		</author>
		<idno type="PMID">6416815</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="2181" to="2185" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Attractions of proteins for small molecules and ions</title>
		<author>
			<persName><forename type="first">G</forename><surname>Scatchard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann N Y Acad Sci</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page">660</biblScope>
			<date type="published" when="1948">1948</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Baskin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Bukowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Kuijper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foster</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lasser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Prunkard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Porte</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Seeley</surname></persName>
		</author>
		<idno type="PMID">8603777</idno>
	</analytic>
	<monogr>
		<title level="j">Diabetes</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="531" to="535" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Leptin regulates bone formation via the sympathetic nervous system</title>
		<author>
			<persName><forename type="first">S</forename><surname>Takeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Elefteriou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Levasseur</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Armstrong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ducy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Karsenty</surname></persName>
		</author>
		<idno type="PMID">12419242</idno>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">111</biblScope>
			<biblScope unit="page" from="305" to="317" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<monogr>
		<title level="m" type="main">A language and environment for statistical computing</title>
		<author>
			<persName><forename type="first">Rc</forename><forename type="middle">R</forename><surname>Team</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2015">2015</date>
			<publisher>R Foundation for Statistical Computing</publisher>
			<pubPlace>Vienna, Austria</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Leptin acts in the periphery to protect thymocytes from glucocorticoid-mediated apoptosis in the absence of weight loss</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Trotter-Mayo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Roberts</surname></persName>
		</author>
		<idno type="PMID">18583419</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="5209" to="5218" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Peripheral leptin regulates bone formation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Kalra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Lindenmaier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Boghossian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">22887758</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="22" to="34" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Morbid obesity attenuates the skeletal abnormalities associated with leptin deficiency in mice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">A</forename><surname>Philbrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Branscum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">T</forename><surname>Iwaniec</surname></persName>
		</author>
		<idno type="PMID">24990938</idno>
	</analytic>
	<monogr>
		<title level="j">J Endocrinol</title>
		<imprint>
			<biblScope unit="volume">223</biblScope>
			<biblScope unit="page" from="1" to="15" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Skeletal effects of estrogen</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Riggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Spelsberg</surname></persName>
		</author>
		<idno type="PMID">8076582</idno>
	</analytic>
	<monogr>
		<title level="j">Endocr Rev</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="275" to="300" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Leptin is required for uncoupling protein-1independent thermogenesis during cold stress</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ukropec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">V</forename><surname>Anunciado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ravussin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Kozak</surname></persName>
		</author>
		<idno type="PMID">16469807</idno>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="2468" to="2480" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Application of VEGFA and FGF-9 enhances angiogenesis, osteogenesis and bone remodeling in type 2 diabetic long bone regeneration</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wallner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Schulte</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hirsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Abraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kneser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lehnhardt</surname></persName>
		</author>
		<idno type="PMID">25742620</idno>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">118823</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">On comparison of several mean values: an alternative approach</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Welch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biometrika</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="330" to="336" />
			<date type="published" when="1955">1955</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Skeletal phenotype of the leptin receptor-deficient db/db mouse</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Callon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Costa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ding</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Dickinson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Naot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">R</forename><surname>Reid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cornish</surname></persName>
		</author>
		<idno type="PMID">21328476</idno>
	</analytic>
	<monogr>
		<title level="j">J Bone Miner Res</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="1698" to="1709" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Leptin induces oncostatin M production in osteoblasts by downregulating miR-93 through the Akt signaling pathway</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">C</forename><surname>Fong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Chang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">H</forename><surname>Tang</surname></persName>
		</author>
		<idno type="PMID">25198901</idno>
	</analytic>
	<monogr>
		<title level="j">Int J Mol Sci</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="15778" to="15790" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
